ArticleEuropean radiology2025

Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients.

Christian Nelles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.